EBUS-TBNA in Elderly Patients with Lung Cancer: Safety and Performance Outcomes [1]
This study evaluated safety and efficacy of EBUS-TBNA in a population of pts 70 or older and compared their results to those of younger patients. Tolerance was better in the older group, and complication rates were similar. Overall accuracy was higher in the older group, possibly related to differences in the underlying diagnoses.
Source name:
Journal of Thoracic Oncology
Resource link: